Roivant initiates pivotal trial of gimsilumab for prevention and treatment of COVID-19-related ARDS April 16, 2020 No Comments
Bristol-Myers Squibb discovers lysophosphatidic acid receptor 1 antagonists April 14, 2020 No Comments
Program to prevent the severe respiratory effects of COVID-19 using LAMELLASOME technology April 9, 2020 No Comments
Solnatide approved for compassionate use in Austria for treatment of severe COVID-19 April 9, 2020 No Comments
Mesoblast's IND for remestemcel-L in COVID-19-related ARDS receives clearance April 7, 2020 No Comments
RSS